Standing ovation at ASCO for cancer pill

7 minute read


Daraxonrasib cut the risk of death by 60% and delivered the strongest late-stage results yet against metastatic pancreatic cancer, prompting emotional scenes at the world's largest cancer meeting.


This content is for AHPRA registered professionals only.
Join Now

End of content

No more pages to load

Log In Register ×